I feel the same away about writing. I didn't become a medical writer to help commercialize drugs, devices, or industry. The good news is that I own the skills. Decision modeling, health economics, biostatistics, clinical medical knowledge, analytics--I now primarily use the skills outside of industry. Imagine if patient populations and healthcare providers were emboldened with the marketing prowess and economic modeling that prevails in medical affairs departments? Yes pharmacodynamic and pharmacokinetic principles are vital to understand how drugs work in our biologic systems but we often confuse pharmacology as health inducing. What we need to understand is the data. What do we really know based on research findings--not misleading headlines.
I will be writing about the 2015 National Conference on Health Statistics in future posts. There is an abundance of relevant information about the health status of the US population, impact of major policy initiatives (ACA), disparities in healthcare, trends in health indicators, as well as recommendations about EHR, quality measures, and population health data. To facilitate the national exchange of health statistics we need to join the dialogue. A surprising absence of representative healthcare stakeholders was evident. I reviewed several peer-reviewed articles that confused the terms below. Why is that important? As you can see here, there are different assumptions that impact data reporting, relevance, and urgency.
A surrogate endpoint is an endpoint observed earlier than the true endpoint (a health outcome) that is used to draw conclusions about the effect of treatment on the unobserved true endpoint. A prognostic marker is a marker for predicting the risk of an event given a control treatment; it informs treatment decisions when there is information on anticipated benefits and harms of a new treatment applied to persons at high risk. A predictive marker is a marker for predicting the effect of treatment on outcome in a subgroup of patients or study participants; it provides more rigorous information for treatment selection than a prognostic marker when it is based on estimated treatment effects in a randomized trial.--Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes
RightCare Action Week is a grassroots initiative for clinicians and others who want to take action that demonstrates how much better our healthcare system can be.
Our healthcare system has strayed from its mission: Healthcare that is effective, affordable, needed and wanted by well-informed patients, and especially, free of clinical decisions that are made with financial or business considerations.
From Oct. 18 to 24, 2015, people like you across the country will take action to show patients that we have not forgotten what good medical care is. Actions can be as simple as taking a deeper social history or doing a house call.
What can you do right now? Sign up for RCAW, vote on actions you’ll support from our growing list of possibilities, or suggest one of your own.
Potential themes or actions that:
RightCareActionWeek.org is designed so that anyone can suggest or discuss activities on the forum.
- Highlight the conflict between the healing culture and business culture
- “Suspend business as usual”
- Connect patients to clinicians and clinicians to their colleagues to provide better care
- Encourage clinicians to take as much time as needed with patients
The only way to transform healthcare is if we present what better healthcare looks like. RCAW is our chance to do that. Sign up to join us now.
RCAW is an initiative of the RightCare Alliance.